http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
공동주택단지의 원격검침 빅데이터를 활용한 실제 유틸리티 소비 패턴 분석 및 최적 용량 산정
박은동(Park Eun-dong),최관호(Choi Gwan-ho),김효준(Kim Hyo-jun),유병국(Rue Byung-gook),이효남(Lee Hyo-nam) 대한설비공학회 2018 대한설비공학회 학술발표대회논문집 Vol.2018 No.6
In case of Korea, apartment housing accounts for a large portion in whole residential type. For apartment construction, capacity estimation of whole apartment complex should be conducted at a early design stage. Generally, a facility capacity of apartment complex is estimated by local code, regulation, and usage of space. However, this design plan is not a proper facility capacity, because it is not reflected in real utility consumption tendency. The aim of this study is to analyze real utility consumption data of apartment and search optimal facility design capacities based on the data analysis results focused on four utilities. This study shows real utilities consumption of apartment complex is lower than current design plan. Thus, it is possible to reduce construction cost related to utility facilities.
박은동(Eun-Dong Park),김효준(Hyo-Jun Kim) 대한설비공학회 2012 대한설비공학회 학술발표대회논문집 Vol.2012 No.6
This study aims to prevent Construction Defect and to serve the best Quality Control by introducing case of a large General Hospital Construction.
위암 치료 후 자궁 내에 발생한 단독 전이성 선암 1 예
김형중 ( Kim Hyeong Jung ),오영림 ( O Yeong Lim ),이천준 ( Lee Cheon Jun ),김흥열 ( Kim Heung Yeol ),김원규 ( Kim Won Gyu ),김성한 ( Kim Seong Han ),박은동 ( Park Eun Dong ),전창완 ( Jeon Chang Wan ),윤명희 ( Yun Myeong Hui ),신 대한산부인과학회 2004 Obstetrics & Gynecology Science Vol.47 No.2
The uteru is an unusual site for metastasis from an extrapelvic neoplasm. Metastasis of gastric cancer to the uterus is rare. We experienced a patient who underwent a gastrectomy and chemotherapy due to gastric cancer and who subsequently suffered a solitary metastatic adenocarcinoma of the uterus from the primary gastric cancer. Similar to Krukenberg tumors of the ovary, lymphatic dissemination is regarded as the route of metastasis from the stomach to the uterine. We report this case with a brief review of literature.
이천준 ( Lee Cheon Jun ),최종열 ( Choe Jong Yeol ),김흥열 ( Kim Heung Yeol ),김원규 ( Kim Won Gyu ),김성한 ( Kim Seong Han ),박은동 ( Park Eun Dong ),공은희 ( Gong Eun Hui ) 대한산부인과학회 2003 Obstetrics & Gynecology Science Vol.46 No.9
The leiomyoma of the uterus is most common benign genital tumor in women of reproductive age but occurs in the vagina rarely and may be confused with a variety of vaginal tumors. A preoperative diagnosis is seldom made. Recently we experienced a case of v
난소 종양에서의 MAGE (Melanoma Antigen Gene) 유전자 발현
이천준 ( Chun June Lee ),남영일 ( Young Il Nam ),서자영 ( Ja Young Seo ),이인철 ( In Cheol Lee ),김영환 ( Young Hwan Kim ),김원규 ( Won Gyu Kim ),김흥열 ( Heung Yeol Kim ),김성한 ( Sung Han Kim ),박은동 ( Eun Dong Park ),김영옥 ( 대한산부인과학회 2003 Obstetrics & Gynecology Science Vol.46 No.6
목적 : 대부분의 난소암이 진행된 시기에 발견되기 때문에 효과적인 치료법의 대안이 필요하다는 점을 고려할 때 난소암에서 MAGE 유전자 발현을 조사하여 그 발현과 면역 요법의 적절성을 연구하는 것은 난소암의 치료에 의미가 있다고 생각된다. 이에 저자는 정상 난소 조직, 비종양성 난소 질환과 양성 및 악성 난소 종양에서의 MAGE 1-6 common primer를 이용한 nested RT-PCR법으로 MAGE 유전자 발현을 조사하여 MAGE 유전자를 이용 Objective : Chemotherapy of ovarian cancer has a main role in the post-surgical treatment of ovarian cancer. However, relapsing patients are usually resistant to an additional chemotherapy. The development of immunotherapy is therefore needed to offer oth
김원규,박은동,주은희 대한부인종양 콜포스코피학회 1995 Journal of Gynecologic Oncology Vol.6 No.1
The incidence in women less than 35 years of age is increasing despite an overall decrease in newly diagnosed invasive cervical cancer among all age groups. However the influence of young age on prognosis remains controversial. So 163 patients of invasive cervical cancer in women aged 35 or less treated from Jan. 1, 1984 to Dec. 31. 1993 at the Department of Obstetrics and Gynecology, Kosin Medical College, Pusan, Korea, were studied retrospectively. We obtained the following results; The 5 - year survival rates by clinical stage were 88.7Y% in stage I b, 71.5% in stage IIa, 31.2% in stage IIb and O% in stage III or above. The lymph node metastasis rates by stage in RAH group, were 21.3% in stage I b and 31.8% in stage IIa. The lymph node metastasis rates by lesion size in RAH group, were 19.2% in 2cm below, 20.7% in 2-4cm and 40.0% in 4cm above. The 5 - year survival rates in RAH group were 74,9% in lymph node positive group and 89.0% in lymph node negative group. The recurrence rates by clinical stage were 0% in stage Ia, 20.6% in stage I b, 22.2% in stage IIa, 50.0% in stage Ilb and 90.9% in stage III or above.
김동휘,박은동,주은희,유건상 대한부인종양 콜포스코피학회 1996 Journal of Gynecologic Oncology Vol.7 No.2
To evaluate the effectiveness of conization in the diagnosis of cervical cancer, the histopathologic finding of 464 consecutive cases were analized with respect to the cytology, punch biopsy and hysterectomy. Cold knife conization was performed under direct visualization(naked eye conization) from January, 1987 to Octorber 1994 at department of Obstetrics and Gynecology, Kosin Medical Center. The results were summerized as follows : 1. The rate of agreement and underdiagnosis of between pap smear and naked eye conization were 43.7% and 47%. 2. The rate of agreement and underdiagnosis of between punch biopsy and naked eye conization were 64.5% and 21.8% 3. Subsequent hysterectomy was done on the 382 case and their incidence of residual disease rate was 44.2%(169 cases). Their incidence of residual lesion was increased with severity of the carcinomatous change. 4. The rate of complication undergoing conization was 8.4%(39 cases).
김동휘,박은동,이천준,안은모,여태홍 대한부인종양 콜포스코피학회 1999 Journal of Gynecologic Oncology Vol.10 No.3
Recently, the bcl-2 and p53 protein have been recognized as important factors that is contributed to programmed cell death. The objective of this study was to evaluate the prognostic significance of bcl-2 and p53 protein expression in uterine cervical carcinoma. The expression of bcl-2 and p53 in 59 cases of uterine cervical carcinoma (stage IB to IIB) were surgically treated from January 1993 to June 1994. The expression of bcl-2 and p53 was examined by immunohistochemical method using formalin fixed paraffin embedded tissue specimens. The 48 cases were squamous cell carcinoma and 11 cases were adenocarcinoma. The results were as follows: 1. The expression rate of bcl-2 protein was 28.8%(17/59) and there was no significant correlation between the expression of bcl-2 protein and the clinicopathologic parameters (histologic type, grade, FIGO stage, cervical invasion depth, lymph node metastasis, parametrial invasion, tumor size, neoadjuvant chemotherapy response, recurrence, survival). 2. The expression rate of p53 protein was 32.2%(19/59) and there was no significant correlation between expression of p53 protein and the clinicopathologic parameters. 3. There was significant correlation between and expression of bcl-2 and p53 protein (P 0.05). In conclusion, bcl-2 and p53 protein are thought to be possible factors in the carcinogenesis of uterine cervical carcinoma and correlate with progression of it. But further study will be required to clarify the role of bcl-2 and p53 in carcinogenesis of the uterine cervix.
김원규,박은동,주은희,유건상 대한부인종양 콜포스코피학회 1996 Journal of Gynecologic Oncology Vol.7 No.2
For the clinical analysis and evaluation on the patients with gestational trophoblastic disease(GTD), a study was done retrospectively on 114 patients with GTD(60 in Hydatidiform mole, 10 in invasive mole, 44 in choriocarcinoma) treated from Jan. 1, 1985 to Dec. 31, 1994 at the Department of Obstetrics and Gynecology, Kosin Medical College, Pusan, Korea. We obtained the following results ; The incidence of GTD was 1 per 73 deliveries in H. mole, 1 per 437 deliveries in invasive mole, and 1 per 99 deliveries in choriocarcinoma. The most prevalent age was 21-40 groups. Abnormal vaginal bleeding was a main symptom and sign. 30.6% of H. mole was managed by dilatation and curettage. 90.0% of invasive mole and 51.4% of choriocarcinoma were managed by surgical treatment and chemotherapy. The overall remissinon rate of choriocarcinoma was 71.4%(100.0% in stage I, 66.7% in stage II, 54.5% in stage III, 50.0% in stage IV).